What do you think of pharmaceutical investment in 2023?
2022 has experienced the most difficult year for pharmaceutical investment in the past five years. The Fed’s unexpected interest rate hike has compressed liquidity and the equity market. The prevention and control of the epidemic has brought concerns to the economy and the capital market. Most investors have lost confidence in medicine, and the friction […]
What do you think of pharmaceutical investment in 2023? Read More »